Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Value-Based Cancer Care

OPEN Health expands offering with the launch of a new Learning & Development specialist team

Enhanced expertise to deliver impactful internal training programmes for healthcare clients

OPEN Health

Spotlight interview: 15 minutes on healthcare communications in gene therapy

Gavin Jones, Director of Rare Disease, OPEN Health takes 15 minutes to answer some key questions on healthcare communications in gene therapy

OPEN Health

- PMLiVE

The changing nature of approvals – what does the future hold?

The 2019 CMR International Pharmaceutical R&D Factbook

- PMLiVE

W2O acquires advertising and medical education agency 21GRAMS

Acquisition adds 150 experts to the W2O team

- PMLiVE

Lilly will aim for one $1bn-$5bn deal per quarter in 2020

Company seeks to bolster pipeline with a string of M&A activity

- PMLiVE

J&J pushes to expand Imbruvica label after clinical success

Eyes the frontline setting in chronic lymphocytic leukaemia

- PMLiVE

FDA delays decision on Intercept’s NASH drug by three months

Action date pushed back to 26 June

- PMLiVE

20/20 vision

Predicting the year ahead for healthcare communications

- PMLiVE

Lucid Group adds more magic to the mix with four new hires

Leading Edge, a Lucid Group company, injects new talent into its client services and medical writing teams. Miranda Harrison joins the team as its Client Operations Director. Miranda is a...

Lucid Group Communications Limited

- PMLiVE

Communiqué Awards 2020 is now open for entry

This year's programme sees the introduction of two new categories

- PMLiVE

Newly-listed BioNTech buys Neon to boost cell therapy assets

German biotech has agreed to pay $67m in the deal

- PMLiVE

FDA committee rejects Intellipharmaceutics’ opioid drug Aximris

Verdict closely follows rejection of Nektar’s opioid analgesic

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links